米国の末梢神経損傷市場規模、シェア、動向分析レポート：製品/治療別、手術別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

米国の末梢神経損傷市場の成長と動向

Grand View Research, Inc.の最新レポートによると、米国の末梢神経損傷市場規模は2030年までに7億1,250万米ドルに達し、2025～2030年のCAGRは7.4％を記録すると推定されます。

同市場の成長は、米国における医療支出の増加、末梢神経損傷の有病率の増加、研究開発への注目の高まり、低侵襲処置に対する患者の嗜好の高まりによるものです。

技術の進歩は、米国における末梢神経損傷治療のセグメントに革命をもたらしています。神経移植片、神経導管、神経刺激装置などの新しく革新的な治療オプションは、治療成績の向上と患者の早期回復に役立っています。さらに、末端神経縫合術や神経減圧術などの低侵襲手術手技の使用は、回復が早いという特典があるため、患者の間で人気を集めています。こうした医療技術の進歩は、より効果的で侵襲の少ない治療を提供することで市場の成長を促進しています。

主要な市場参入企業による投資や、学界、産産業、医療機関の協力により、研究開発努力が推進され、新たな治療の発見につながっています。例えば、2022年6月、再生医療の主要バイオテクノロジー企業であるVascudyne, Inc.は、Regenerative Medicine Minnesotaから"Production of a Peripheral Nerve Wrap Using Tissue Tubes from Regenerative Engineering "と題する研究調査のための助成金を授与されました。この研究には2022年6月から1年間、10万米ドルが提供され、バスキュダインのTRUE Tissue技術が活用されます。

COVID-19の大流行は、回復時間の短縮、潜在的な低コスト、より良い治療オプション、遠隔医療技術との統合などの利点を提供するため、低侵襲手術の需要を押し上げています。これらの要因は、米国の末梢神経損傷市場にプラスの影響を与える可能性があります。

米国の末梢神経損傷市場レポートハイライト

• 製品/治療別では、自家移植、同種移植、合成導管などの神経移植技術の急速な進歩により、神経移植部門が2024年の米国末梢神経損傷市場シェアで65.1%を占め、圧倒的な強さを示しました。
• 手術別では、直接神経修復術が米国末梢神経損傷市場を独占し、約42.5％の最大売上シェアを占めました。これは重症例に対する外科治療のゴールドスタンダードと考えられています。
• 用途別では、上肢セグメントが2024年の米国末梢神経損傷市場シェアで81.2%を占め、最大でした。偶発的な転倒やギラン・バレー症候群、糖尿病、手根管症候群などの病状が増加しており、このセグメントを牽引すると予想されています。
• 最終用途別では、2024年には病院セグメントが市場を独占しました。病院数の増加と病院での手術症例の増加が、このセグメントを押し上げると予想されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の末梢神経損傷市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析

第4章 米国の末梢神経損傷市場：製品/治療ビジネス分析

• 製品/治療市場シェア、2024年と2030年
• 製品/治療セグメントダッシュボード
• 市場規模と予測と動向分析、製品/治療別、2018～2030年
• 神経移植
• 生体材料

第5章 米国の末梢神経損傷市場：手術ビジネス分析

• 手術市場シェア、2024年と2030年
• 手術セグメントダッシュボード
• 市場規模と予測と動向分析、手術別、2018～2030年
• 直接神経修復術
• 神経移植
• 幹細胞療法
• 内部神経溶解
• 神経縫合術

第6章 米国の末梢神経損傷市場：用途ビジネス分析

• 用途市場シェア、2024年と2030年
• 用途セグメントダッシュボード
• 市場規模と予測と動向分析、用途別、2018～2030年
• 上肢
• 下肢

第7章 米国の末梢神経損傷市場：最終用途ビジネス分析

• 最終用途市場シェア、2024年と2030年
• 最終用途セグメントダッシュボード
• 市場規模と予測と動向分析、最終用途別、2018～2030年
• 病院
• クリニック
• 外来手術センター
• その他

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Axogen Corporation
  • Stryker
  • Regenity
  • Integra LifeSciences Corporation
  • TOYOBO CO., LTD.
  • Alafair Biosciences, Inc.
  • SYNOVIS MICRO COMPANIES ALLIANCE, INC.,（BAXTER INTERNATIONAL INC.）

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. U.S. peripheral nerve injury market, by product/therapies, 2018 - 2030 (USD Million)
• Table 4. U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
• Table 5. U.S. peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
• Table 6. U.S. peripheral nerve injury market, end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 U.S. peripheral nerve injury market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market snapshot
• Fig. 8 Segment outlook
• Fig. 9 Competitive landscape
• Fig. 10 U.S. peripheral nerve injury market dynamics
• Fig. 11 U.S. peripheral nerve injury market: Porter's five forces analysis
• Fig. 12 U.S. peripheral nerve injury market: PESTLE analysis
• Fig. 13 U.S. peripheral nerve injury market: Products/therapies segment dashboard
• Fig. 14 U.S. peripheral nerve injury market: Products/therapies market share analysis, 2024 & 2030
• Fig. 15 Nerve grafting market, 2018 - 2030 (USD Million)
• Fig. 16 Autograft market, 2018 - 2030 (USD Million)
• Fig. 17 Allograft market, 2018 - 2030 (USD Million)
• Fig. 18 Stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 19 Biomaterial market, 2018 - 2030 (USD Million)
• Fig. 20 Nerve conduit market, 2018 - 2030 (USD Million)
• Fig. 21 Nerve protector market, 2018 - 2030 (USD Million)
• Fig. 22 Nerve connector market, 2018 - 2030 (USD Million)
• Fig. 23 U.S. peripheral nerve injury market: Surgery segment dashboard
• Fig. 24 U.S. peripheral nerve injury market: Surgery market share analysis, 2024 & 2030
• Fig. 25 Direct nerve repair market, 2018 - 2030 (USD Million)
• Fig. 26 Nerve grafting market, 2018 - 2030 (USD Million)
• Fig. 27 Stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 28 Carpal tunnel release market, 2018 - 2030 (USD Million)
• Fig. 29 Internal neurolysis market, 2018 - 2030 (USD Million)
• Fig. 30 Neurorrhaphy market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. peripheral nerve injury market: Application segment dashboard
• Fig. 32 U.S. peripheral nerve injury market: Application market share analysis, 2024 & 2030
• Fig. 33 Upper extremities market, 2018 - 2030 (USD Million)
• Fig. 34 Lower extremities market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. peripheral nerve injury market: End use segment dashboard
• Fig. 36 U.S. peripheral nerve injury market: End use market share analysis, 2024 & 2030
• Fig. 37 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 38 Clinics market, 2018 - 2030 (USD Million)
• Fig. 39 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 40 Others market, 2018 - 2030 (USD Million)
• Fig. 41 Company categorization
• Fig. 42 Company market position analysis
• Fig. 43 Strategic framework

U.S. Peripheral Nerve Injuries Market Growth & Trends:

The U.S. peripheral nerve injuries market size is estimated to reach USD 712.5 million by 2030, registering a CAGR of 7.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to increasing healthcare expenditure in the U.S., an increasing prevalence of peripheral nerve injuries, growing focus on research and development, and a growing patient preference for minimally invasive procedures.

Technological advancements are revolutionizing the field of peripheral nerve injury treatment in the U.S. New and innovative treatment options such as nerve grafts, nerve conduits, and neurostimulation devices are providing improved outcomes and helping patients recover faster. Additionally, the use of minimally invasive surgical techniques, such as end-to-end nerve sutures and nerve decompression procedures, is gaining popularity among patients due to their benefits of faster recovery times. These advancements in medical technology are driving the growth of the market by providing more effective and less invasive treatment options.

Investments from key market players and collaborations between academia, industry, and healthcare institutions are driving R&D efforts, leading to the discovery of new treatment modalities. For instance, in June 2022, Vascudyne, Inc., a leading biotechnology company in regenerative medicine, was awarded a grant from Regenerative Medicine Minnesota for a research study titled "Production of a Peripheral Nerve Wrap Using Tissue Tubes from Regenerative Engineering." The study will be funded with USD 100,000 for one year, starting in June 2022, and will utilize Vascudyne's TRUE Tissue technology.

The COVID-19 pandemic has boosted the demand for minimally invasive procedures as it offer benefits such as shorter recovery times, potentially lower costs, better treatment options, and integration with telemedicine technologies. These factors may impact the market for U.S. peripheral nerve injuries positively.

U.S. Peripheral Nerve Injuries Market Report Highlights:

• Based on product/therapies, Nerve grafting segment dominated the U.S. peripheral nerve injury market share in 2024, accounting for 65.1%, owing to rapid advancements in nerve grafting techniques, such as autografts, allografts, and synthetic conduits
• Based on surgery, direct nerve repair segment dominated the U.S. peripheral nerve injury market and held the largest revenue share of nearly 42.5%. It is considered the gold standard of surgical treatment for severe cases
• Based on application, upper extremities segment held the largest U.S. peripheral nerve injury market share in 2024, accounting for 81.2%. increasing incidence of accidental falls and medical conditions, such as Guillain-Barre syndrome, diabetes, & carpal tunnel syndrome, is expected to drive the segment
• Based on end use, hospitals segment dominated the market in 2024. Increasing number of hospitals and surgical cases in hospitals are expected to boost the segment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products/Therapies
  • 1.2.2. Surgery
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Peripheral Nerve Injury Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Peripheral Nerve Injury Market: Products/Therapies Business Analysis

• 4.1. Products/Therapies Market Share, 2024 & 2030
• 4.2. Products/Therapies Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Products/Therapies, 2018 to 2030 (USD Million)
• 4.4. Nerve Grafting
  • 4.4.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
  • 4.4.2. Autograft
    • 4.4.2.1. Autograft Market, 2018 - 2030 (USD Million)
  • 4.4.3. Allograft
    • 4.4.3.1. Allograft Market, 2018 - 2030 (USD Million)
  • 4.4.4. Stem Cell Therapy
    • 4.4.4.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 4.5. Biomaterial
  • 4.5.1. Biomaterial Market, 2018 - 2030 (USD Million)
  • 4.5.2. Nerve Conduit
    • 4.5.2.1. Nerve Conduit Market, 2018 - 2030 (USD Million)
  • 4.5.3. Nerve Protector
    • 4.5.3.1. Nerve Protector Market, 2018 - 2030 (USD Million)
  • 4.5.4. Nerve Connector
    • 4.5.4.1. Nerve Connector Market, 2018 - 2030 (USD Million)
  • 4.5.5. Nerve Wraps
    • 4.5.5.1. Nerve Wraps Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Nerve Injury Market: Surgery Business Analysis

• 5.1. Surgery Market Share, 2024 & 2030
• 5.2. Surgery Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Surgery, 2018 to 2030 (USD Million)
• 5.4. Direct Nerve Repair
  • 5.4.1. Direct Nerve Repair Market, 2018 - 2030 (USD Million)
• 5.5. Nerve Grafting
  • 5.5.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
• 5.6. Stem Cell Therapy
  • 5.6.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 5.7. Internal Neurolysis
  • 5.7.1. Internal Neurolysis Market, 2018 - 2030 (USD Million)
• 5.8. Neurorrhaphy
  • 5.8.1. Neurorrhaphy Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Nerve Injury Market: Application Business Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Upper Extremities
  • 6.4.1. Upper Extremities Market, 2018 - 2030 (USD Million)
• 6.5. Lower Extremities
  • 6.5.1. Lower Extremities Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Peripheral Nerve Injury Market: End Use Business Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. End Use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 7.5. Clinics
  • 7.5.1. Clinics Market, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Axogen Corporation.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Stryker
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Regenity
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Integra LifeSciences Corporation.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. TOYOBO CO., LTD.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Alafair Biosciences, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC., (BAXTER INTERNATIONAL INC.)
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives